Diabetes mellitus: Simple classification and corresponding treatment;Diabetes mellitus: Eenvoudige classificatie en bijpassende behandeling

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 18, 2006, Pages 1007-1012

  Simsek, S ^a   Diamant, M ^a   Eekhoff, E M W ^a   Heine, R J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BODY MASS; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE CLASSIFICATION; FAMILY HISTORY; HEARING IMPAIRMENT; HUMAN; HYPERGLYCEMIA; INHERITANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JUVENILE DIABETES MELLITUS; MATERNAL DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; REVIEW; SYMPTOM;

BODY MASS INDEX; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; WOLFRAM SYNDROME;

EID: 33646503229     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28:S37-42.
2. Hoekstra JBL, Koning EJP de. Diabetes mellitus, maar welk type? Ned Tijdschr Geneeskd. 2004;148:761-4.
3. Diamant M, Eekhoff EMW, Heine RJ, Simsek S. Diabetes mellitus, maar welk type? Ned Tijdschr Geneeskd. 2004;148:1265-6.
4. Simsek S, Diamant M, Eekhoff EM, Heine RJ. Waarom wordt bij de start van orale therapie bij diabetes mellitus type 2 niet altijd begonnen met metformine in plaats van sulfonylureumderivaten, ook bij patiënten die een QI hebben van < 27? In: De meest gestelde vragen over: diabetes mellitus. Vademecum permanente nascholing huisartsen. Houten: Bohn Stafleu van Loghum; 2005.
5. Rutten GEHM, Verhoeven S, Heine RJ, Grauw WJC de, Cromme PVM, Reenders K, et al. NHG-standaard Diabetes mellitus type 2. Huisarts Wet. 1999;42:67-84.
6. Houweling ST, Kleefstra N, Ballegooie E van, Miedema K, Rischen R, Heeg JE. Diagnostiek van diabetes mellitus: beperkte plaats voor draagbare glucosemeters. Ned Tijdschr Geneeskd. 2005;149:694-7.
7. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039-57.
8. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care. 1993;16:902-10.
9. Szepietowska B, Szelachowska M, Kinalska I. Do latent autoimmune diabetes of the adult (LADA) patients require insulin at diagnosis?: response to Pozzilli and di Mario. Diabetes Care. 2002;25:1662-3.
10. Maruyama T, Shimada T, Kanatsuka A, Kasuga A, Takei I, Yokoyama I, et al. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report. Ann N Y Acad Sci. 2003;1005:362-9.
11. Gale EAM. Latent autoimmune diabetes in adults: a guide for the perplexed. Diabetologia. 2005;48:2195-9.
12. Lohmann T, Nietzschmann U, Kiess W. 'Lady-like': is there a latent autoimmune diabetes in the young? Diabetes Care. 2000;23:1707-8.
13. Olijhoek JK, Martens FMAC, Banga JD, Visseren FLJ. Het metabool syndroom: een cluster van vasculaire risicofactoren. Ned Tijdschr Geneeskd. 2005;149:859-65.
14. Dekker JM, Diamant M, Nijpels G, Heine RJ. Het metabool syndroom: beperkte meerwaarde voor de klinische praktijk. Ned Tijdschr Geneeskd. 2005;149:855-8.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
16. Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia. 2002;45:283-5.
17. Maassen JA, Lemkes HHPJ, Losekoot M. Van gen naar ziekte; 'maturity-onset diabetes of the young' (MODY), monogenetisch overervende vormen van diabetes mellitus. Ned Tijdschr Geneeskd. 2001;145: 1352-3.
18. Losekoot M, Broekman AJ, Breuning MH, Koning EJP de, Romijn JA, Maassen JA. Moleculaire diagnostiek bij aanwijzingen voor 'maturity onset diabetes of the young'; resultaten bij 184 patiënten. Ned Tijdschr Geneeskd. 2005;149:139-43.
19. Maassen JA, Ouweland JMW van den, Losekoot M, Lemkes HHPJ. Van gen naar ziekte; mutatie in mitochondrieel DNA en maternaal overervende diabetes mellitus met doofheid (MIDD). Ned Tijdschr Geneeskd. 2001;145:1153-4.
20. Heinze E, Thon A. Honeymoon period in insulin-dependent diabetes mellitus. Pediatrician. 1983-85;12:208-12.
21. Ruige JB, Batstra MR, Aanstoot HJ, Bouter LM, Bruining GJ, Neeling JN de, et al. Low prevalence of antibodies to GAD&5 in a 50- to 74-year-old general Dutch population. The Hoorn study. Diabetes Care. 1997;20:1108-10.
22. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999;48:150-7.
23. Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, et al. Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care. 1999;22:1347-53.
24. Pozzilli P, di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001;24: 1460-7.
25. Landin-Olsson M. Latent autoimmune diabetes in adults. Ann N Y Acad Sci. 2002;958:112-6.
26. Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, et al. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime study). Diabetes Care. 2002;25:995-1001.
27. Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI, et al. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. ADOPT Study Group. Diabetes. 2004;53:3193-200.
28. Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, et al. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes. Study Group for the Genetics of Diabetes in Sardinia. J Clin Endocrinol Metab. 2004;89: 5675-82.
29. Hamaguchi K, Kimura A, Kusuda Y, Yamashita T, Yasunami M, Takahasi M, et al. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes. Diabetes Res Clin Pract. 2004;66:163-71.
30. Maassen JA. Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Genet. 2002;115:66-70.